EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Progressive LV Dysfunction and Adverse Outcomes After Aortic Valve Replacement With Bioprosthetic Valves in Young Patients

Alexander C Egbe iD, Heidi M Connolly iD, Ahmed T Abdelhalim iD, Maan Jokhadar iD, Luke J Burchill iD, Joseph A Dearani iD, Hartzell V Schaff iD

Circulation: Cardiovascular Imaging · 2025

DOI: 10.1161/circimaging.124.017905 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Imaging, 2025. Verfasst von Alexander C Egbe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine (A.C.E., H.M.C., A.T.A., M.J., L.J.B.), Mayo Clinic Rochester, MN. Hauptthemen laut MEDLINE: Bioprosthesis, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Bioprosthetic valve dysfunction and reoperations/reinterventions are common after aortic valve replacement (AVR) with bioprosthetic valves, leading to cycles of left ventricular (LV) pressure overload and unloading. The purpose of this study was to compare postoperative changes in LV structure and function and their relationship to clinical outcomes in young patients who underwent AVR with bioprosthetic valves (Bio_AVR group) versus mechanical prosthetic valves (Mech_AVR group). METHODS: Retrospective study of adults with congenital heart disease who underwent AVR at Mayo Clinic (2003–2023). The Bio_AVR group was matched 1:2 to the Mech_AVR group. LV indices (LV mass index, relative wall thickness, LV global longitudinal strain, averaged e′, and averaged E/e′) and clinical indices (NT-proBNP [N-terminal pro-B-type natriuretic peptide] and New York Heart Association class) were assessed preoperatively, and at 1, 5, and 10 years post-AVR. RESULTS: We studied 151 and 302 patients in the Bio_AVR and Mech_AVR groups, respectively (age 38±16 years, 58% males). Both groups had similar LV and clinical indices at baseline and 1 year post-AVR. However, the Bio_AVR group had higher LV mass index, relative wall thickness, and averaged E/e′, and lower averaged e′ and LV global longitudinal strain at 5 and 10 years post-AVR. Of 51 patients from the Bio_AVR group who underwent a second AVR, there was less robust improvement in LV indices and clinical indices after the second AVR compared with the first AVR. CONCLUSIONS: AVR with a bioprosthetic valve was associated with progressive LV hypertrophy and dysfunction, and worsening clinical status compared with mechanical prosthetic valves. This provides further evidence against the use of bioprosthetic AVR in young patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioprosthesisHeart Valve ProsthesisHeart Valve Prosthesis ImplantationVentricular Dysfunction, LeftAortic ValveVentricular Function, LeftHumansMaleFemaleRetrospective StudiesAdultMiddle AgedTreatment OutcomeProsthesis DesignDisease ProgressionTime FactorsProsthesis FailureRisk FactorsYoung Adult

Stichwörter der Autor:innen

adulthumanshypertrophyreoperation

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine (A.C.E., H.M.C., A.T.A., M.J., L.J.B.), Mayo Clinic Rochester, MN.
  • Department of Cardiovascular Surgery, Mayo Clinic Rochester, MN (J.A.D., H.V.S.).

ORCID-Profile: Alexander C Egbe, Heidi M Connolly, Ahmed T Abdelhalim, Maan Jokhadar, Luke J Burchill, Joseph A Dearani, Hartzell V Schaff

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Egbe, A. C., Connolly, H. M., Abdelhalim, A. T., Jokhadar, M., Burchill, L. J., Dearani, J. A., & Schaff, H. V. (2025). Progressive LV Dysfunction and Adverse Outcomes After Aortic Valve Replacement With Bioprosthetic Valves in Young Patients. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.124.017905

Vancouver

Egbe AC, Connolly HM, Abdelhalim AT, Jokhadar M, Burchill LJ, Dearani JA, et al. Progressive LV Dysfunction and Adverse Outcomes After Aortic Valve Replacement With Bioprosthetic Valves in Young Patients. Circulation: Cardiovascular Imaging. 2025. doi:10.1161/circimaging.124.017905

BibTeX
@article{Egbe2025,
  author = {Egbe, Alexander C and Connolly, Heidi M and Abdelhalim, Ahmed T and Jokhadar, Maan and Burchill, Luke J and Dearani, Joseph A and Schaff, Hartzell V},
  title = {Progressive LV Dysfunction and Adverse Outcomes After Aortic Valve Replacement With Bioprosthetic Valves in Young Patients},
  journal = {Circulation: Cardiovascular Imaging},
  year = {2025},
  doi = {10.1161/circimaging.124.017905}
}
Kostenlos starten →